KRTAP10 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the KRTAP10 proteins. KRTAP, or keratin-associated proteins, are crucial components of the hair follicle structure, where they form the cross-linking matrix that binds keratin fibers. KRTAP10 refers to a subset of these proteins involved in the formation and maintenance of this structural integrity. The inhibitors in this class disrupt the normal interaction and functionality of KRTAP10 proteins, affecting the assembly of keratin filaments. These inhibitors work at the molecular level by binding to specific regions of the KRTAP10 proteins, altering their conformation or preventing their interaction with keratin or other associated proteins, which results in changes to the overall structural dynamics of keratin matrices.
Chemically, KRTAP10 inhibitors often belong to a diverse range of molecular scaffolds, depending on their specific mechanism of action. Some may function through small-molecule inhibition, while others might involve larger, more complex biomolecules. Their molecular structure typically includes functional groups designed to interact with the protein's active or binding sites. These inhibitors can be designed to have high specificity for KRTAP10 over other keratin-associated proteins, which is critical to avoid non-specific effects on other keratin-forming processes. The precise mechanism of inhibition can vary, with some compounds acting allosterically by changing the protein's shape and others competitively, directly blocking the interaction of KRTAP10 with keratin fibers. Research in this area focuses on understanding the molecular architecture of these inhibitors and how their binding kinetics influence the assembly and function of keratin structures.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may inhibit KRTAP10 expression by intercalating into DNA, blocking RNA synthesis and affecting transcription of KRTAP10. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide might inhibit KRTAP10 expression by blocking protein synthesis, thereby reducing the production of KRTAP10 protein. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $255.00 | ||
Actinomycin C could potentially inhibit KRTAP10 expression similarly to Actinomycin D, by interfering with RNA synthesis. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin may inhibit KRTAP10 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of KRTAP10. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin might inhibit KRTAP10 expression by prematurely terminating protein synthesis, thereby reducing KRTAP10 production. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin has been suggested to inhibit KRTAP10 expression by inhibiting protein synthesis at the translational level, affecting KRTAP10 production. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin may inhibit KRTAP10 expression by intercalating into DNA and impacting transcription, reducing the synthesis of KRTAP10. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide could potentially inhibit KRTAP10 expression by affecting topoisomerase II activity, influencing DNA transcription and KRTAP10 synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $360.00 $475.00 | 20 | |
Blasticidin S may inhibit KRTAP10 expression by interfering with protein synthesis, potentially reducing the production of KRTAP10. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C might inhibit KRTAP10 expression by crosslinking DNA, affecting transcription and potentially reducing KRTAP10 synthesis. | ||||||